Title: Effect of Addition of Dexmedetomidine as an Adjuvant to Levobupivacaine in Supraclavicular Brachial Plexus Block

Authors: Dr Aneesh K V, Dr Rajani Gandhi

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i4.55

Abstract

INTRODUCTION

Brachial plexus nerve blocks have become important in clinical practice because of their role in post-operative pain relief1, shortening of patient recovery time and avoiding risks and adverse effects of General anaesthesia2,3. Hence,peripheral nerve blockade is now a well-accepted concept for comprehensive anesthetic care. In 1928, Kulenka-mpff and Persky published their experiences with a thousand blocks without apparent major complications3. The subclavian (Supraclavicular) perivascular technique was first developed by Alon Willie and Collins4. The advantage of Supra clavicular technique over other brachial plexus approaches are its rapid onset and complete predictable anesthesia. Levobupivacaine is a high potent ,long acting amide local anaesthetic, with less cardio toxic effects5. Levobupivacaine is a local anesthetic with long duration, having similar pharmacology to bupivacaine; however, it has a wider safety margin and was shown to possess less cardio toxicity in comparison with bupivacaine6,7. So it has been one of the most commonly used local anesthetic for peripheral nerve blocks. Dexmedetomidine is a pharmacolo-gically active dextro isomer of Medetomidine; a selective α2-adrenergic receptor agonist which provides analgesia and sedation8, it provides more hemodynamic stability intense analgesia with less respiratory depression and rapid recovery8,9,10. Numerous studies has shown that the use of local anesthetic agents with adjuvants such as clonidine16 and tramadol for a brachial plexus block to improve the quality and duration of anesthesia, and these studies have shown that the adjuvants may prolong anesthesia and analgesia. Hence here is an attem pt to study the Effect of addition of Dexmedetomidine to Levobupivacaine in supraclavicular brachial plexus block alone for supraclavicular brachial plexus block in prolonging the duration of analgesia in patients undergoing orthopedic surgery of forearm or hand. In this study, we investigated the effects of adding dexmedeto-midine to Levobupivacaine in supraclavicular brachial plexus block. The primary outcome of our study was the duration of analgesia, and the secondary outcome were duration and onset of sensory and motor block and side effects.

References

1.      Kulenkampff, D (1911). "Zur anästhesie-rung des plexus brachialis" [On anesthesia of brachial plexus]. 38: 1337–40.

2.      Hirschel G (1911-07-18). "Die anästhes-ierung des plexus brachialis fuer die operationen an der oberen extremitat" [Anesthesia of the brachial plexus for operations on the upper extremity]. 58: 1555–6.

3.      Kulenkampff, D; Persky, MA (1928). "Brachial plexus anaesthesia: its indications, technique, and dangers". Annals of Surgery 87 (6): 883–91

4.      Winnie AP, Collins VJ. “The subclavian perivascular technique of brachial plexus anesthesia. Anesthesiology”1964;25:35-63

5.      Burlacu CL, Buggy DJ. Update on local anesthetics: focus on levobupivacaine. Ther Clin Risk Manag. 2008 Apr;4(2): 381–92.

6.      Kopacz DJ, Allen HW. Accidental intravenous levobupivacaine. Anesth Analg. 1999 Oct;89(4):1027–9.

7.      Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf Int J Med Toxicol Drug Exp. 2002;25 (3):153–63.

8.      Anju Grewal, Dexmedetomidine: new avenues. J Anaesthesiol Clin Pharmacol july – sept 2011;27: issue 3

9.      Keira P. Mason Dexmedetomidine in Children: Current Knowledge and Future Applications Anesthesia-Analgesia  2011 .

10.  Manpreeth kaur P M sing, Current role of dexmedetomidine in clinical anaesthesia and intensive care. Anaesthesia: Essays and Researches; 5 (2) July - Dec 2011

11.  Jones MEP, Maze M. Can we characterize the central nervous system actions of alpha-2 adrenergic agonists? Br J Anaesth 2001;86(1):1-3.

12.  Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedeto-midine in humans. Anaesthesiology 2009;93;382-94

13.  Pavlin DJ , Rapp et al – Factors affecting discharge time in adult out patients. Anaesthesia Analgesia – 1998; 87:8161.

14.  Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block. Anesth Analg. 2010 Dec;111(6):1548–51.

15.  Singh S, Aggarwal A. A randomized controlled double-blinded prospective study of the efficacy of clonidine added to bupivacaine as compared with bupivacaine alone used in supraclavicular brachial plexus block for upper limb surgeries. Indian J Anaesth. 2010;54(6):552–7.

16.  Foster RH, Markham A. Levobupivacaine: a review of its pharmacology and use as a local anaesthetic. Drugs. 2000 Mar;59(3): 551–79.

17.  Shukla D, Verma A, Agarwal A, Pandey HD, Tyagi C. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine. J Anaesthesiol Clin Pharmacol. 2011;27(4):495–9.

18.  Biswas S, Das RK, Mukherjee G, Ghose T. Dexmedetomidine an Adjuvant to Levobupivacaine in Supraclavicular Brachial Plexus Block: A Randomized Double Blind Prospective Study. Ethiop J Health Sci. 2014 Jul;24(3):203–8.

19.  Brummett CM, Williams BA. Additives to Local Anesthetics for Peripheral Nerve Blockade. Int Anesthesiol Clin. 2011;49(4):104–16.

20.  Swami SS, Keniya VM, Ladi SD, Rao R. Comparison of dexmedetomidine and clonidine (?2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: A randomised double-blind prospective study. Indian J Anaesth. 2012;56(3):243–9.

21.  Kaygusuz K, Kol IO, Duger C, Gursoy S, Ozturk H, Kayacan U, et al. Effects of Adding Dexmedetomidine to Levobupivacaine in Axillary Brachial Plexus Block. Curr Ther Res Clin Exp. 2012 Jun;73(3):103–11.

22.  Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol. 2014 Jan;30(1):36–40.

23.  C P, C DA, L P, F R, P C, D T. Levobupivacaine and ropivacaine in the infraclavicular brachial plexus block. Minerva Anestesiol. 2006 Apr;72(4):217–21.

24.  Chan{“id”:5019604 V, first_name “: ”Vincent, last_name“:”Chan, page_name“: ”VincentChan, domain_name“:”hkust, created_at“:”2013-08-01T20:20:58.402-07:00, et al. Novel Analgesic Adjuncts for Brachial Plexus Block: A Systematic Review [Internet]. [cited 2014 Oct 17]. Available from: http://www.academia.edu/4155469/Novel_Analgesic_Adjuncts_for_Brachial_Plexus_Block_A_Systematic_Review

25.  McClellan KJ, Spencer CM. Levobupiv-acaine. Drugs. 1998 Sep;56(3):355–62; discussion 363–4.

26.  SaudiJAnaesh8572-8653997_022413.pdf [Internet]. [cited 2014 Nov 13]. Available from: http://www.saudija.org/temp/SaudiJAnaesh8572-8653997_022413.pdf

27.  SaudiJAnaesh62109-8747581_022547.pdf [Internet]. [cited 2014 Nov 13]. Available from: http://www.saudija.org/temp/SaudiJAnaesh62109-8747581_022547.pdf

Corresponding Author

Dr Aneesh K V

Assistant Professor, Government Medical College Trivandrum